Associate Editor, Ophthalmology Times
Indian Institute of Technology Kanpur licenses gene therapy technology for hereditary diseases
June 10th 2023IIT Kanpur licensed the technology to Reliance Life Sciences Pvt. Ltd. and this marks the first time a gene therapy related technology has been developed and transferred from an academic institution to a company in India.
Read More
US Federal Trade Commission files a lawsuit to block Amgen’s acquisition of Horizon Therapeutics
May 18th 2023The lawsuit states the $27.8 billion acquisition would allow Amgen to strengthen their drug portfolio and stifle drug competition in a bid to monopolize two fast-growing medications.
Read More
ASCRS 2023: Study of standalone multiple trabecular micro-bypass stents for uncontrolled glaucoma
May 6th 2023Ike Ahmed, MD, sat down with David Hutton, Managing Editor, Ophthalmology Times®, to discuss his presentation on the study of standalone multiple trabecular micro-bypass stents for uncontrolled glaucoma at the ASCRS annual meeting in San Diego
Read More
ASCRS 2023: Antibiotic resistance of intraocular bacterial pathogens
May 6th 2023Penny Asbell, MD, FACS, MBA, sat down with David Hutton, Managing Editor, Ophthalmology Times®, to discuss her presentation on the ARMOR study and the antibiotic resistance of intraocular bacterial pathogens at the ASCRS annual meeting in San Diego
Read More